Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $7.83B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 20,581,016 | $4.836B | 61.8% | $16.43 | +987.5% | COM | 60770K107 |
| — | Rubius Therapeutics Inc | 38,506,526 | $940M | 12.0% | $24.00 | — | COM | 78116T103 |
| SANA | Sana Biotechnology Inc | 34,239,018 | $673M | 8.6% | $32.56 | -30.4% | COM | 799566104 |
| — | Seres Therapeutics Inc | 14,378,802 | $343M | 4.4% | $8.55 | — | COM | 81750R102 |
| — | Evelo Biosciences Inc | 23,030,069 | $316M | 4.0% | $10.39 | — | COM | 299734103 |
| DNLI | Denali Therapeutics Inc | 2,730,263 | $214M | 2.7% | $17.97 | +244.2% | COM | 24823R105 |
| KLDO | Kaleido Biosciences Inc | 19,575,710 | $146M | 1.9% | $13.01 | -45.5% | COM | 483347100 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $135M | 1.7% | $19.16 | -43.1% | COM | 344174107 |
| — | Sigilon Therapeutics Inc | 10,370,369 | $111M | 1.4% | $48.03 | — | COM | 82657L107 |
| — | Axcella Health Inc | 12,548,414 | $50.32M | 0.6% | $8.17 | — | COM | 05454B105 |
| — | Codiak Biosciences Inc | 2,607,303 | $48.31M | 0.6% | $32.30 | — | COM | 192010106 |
| — | Syros Pharmaceuticals Inc | 2,938,494 | $16.02M | 0.2% | $13.87 | — | COM | 87184Q107 |